Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Jenny C. Yip, PsyD, ABPP, shares advice for HCPs who may be struggling with anxiety or depression as a result of months of practicing medicine and managing personal…
An open randomized trial showed that for a first episode of schizophrenia, four second-generation antipsychotics were no more effective than haloperidol, but they did have lower discontinuation rates.…
The investigational antiplatelet agent Prasugrel improves ischemic event rates after percutaneous coronary intervention, whatever type of stent is used, researchers reported at the American College of Cardiology meeting.…
According to the FDA, mortality was substantially higher in patients who had an AneuRx Stent Graft implanted to prevent abdominal aortic aneurysm rupture than in patients who had…
The FDA has posted a warning alerting clinicians of pooled data from 29 placebo-controlled trials of tiotropium that revealed excess strokes among COPD patients on active treatment. References…
New research shows variants in nine genes involved with lipid synthesis and metabolism predicted risk of cardiovascular disease, independently of blood lipid levels. References and Resources Kathiresan S,…
A new study shows that the aromatase inhibitor letrozole can prevent late recurrence of breast cancer. References and Resources Goss P, et al. Late extended adjuvant treatment with…
Statin use at the time of ovarian cancer surgery was associated with a 50% increase in the duration of progression-free survival and with more than a year of…
The Oncologic Drug Advisory Committee said the FDA should mandate a restricted distribution system for cancer patients given erythropoiesis-stimulating agents. References and Resources FDA.gov Sponsored by The Doctor’s…
A meta analysis of more than 2,500 patients from nine trials showed that antibiotics for those who suffer from rhinosinusitis is unnecessary. References and Resources Young J, et…
Results of a Gynecologic Oncology Group study suggest that for patients with recurrent cervical cancer, bevacizumab has demonstrated activity and promise as an option for second or third…
